Indian stocks: Visit www.stage2stocks.com →

KORU Medical Systems, Inc.

Stage 4 · Declining · week 11

As of Oct 22, 2026, KORU Medical Systems is in Stage 4, the downtrend phase, now in week 11 (since Aug 10, 2026). It closed at $3.08, 52.8% below its 52-week high and below its 200-day average, which is falling.

KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. More about the company

$3.08
-1.13% today
$141M · Micro cap
Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is KRMD early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S4 33w
S2 22w
S2 14w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S4 33w → S1 10w → S4 1w → S1 1w → S2 10w → S3 3w → S2 22w → S3 7w → S4 7w → S1 8w → S2 14w → S3 2w → S2 13w → S3 7w → S4 13w → S1 4w → S4 11w current
Total tracked: 165 weeks across 17 stage runs.

KRMD among Medical Instruments & Supplies34th of 51 by relative strength

All 51 →
Stocks in Medical Instruments & Supplies ranked by relative strength, with stage and one-month change
#StockStageRS1M
1PLSEStage 2 · wk 3498+1.3%
2PDEXStage 2 · wk 3697−13.3%
3HBIOStage 2 · wk 1195+3.6%
4ATRCStage 2 · wk 1089−1.1%
5WSTStage 2 · wk 2482+4.8%
6BDXStage 2 · wk 1181+9.8%
7ICUIStage 3 · wk 181+3.1%
8OSURStage 3 · wk 875−4.8%
…34KRMDStage 4 · wk 1135−6.0%
vs 52W High
-52.8%
$2.93 lo$6.52 hi
52.8% below 52W high, deep Stage 4 damage
In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.
Stage Maturity
Week 11
1w13w26w
Week 11, established downtrend
How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.
vs 200 DMA
-24.9%
200 DMA: $4.10 · sloping down
In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.
Rel Volume
0.34x
vs 50-day avg
High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.
Trend Health
↓
Short-term trend rolling over
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
-6.0%
3M
-19.7%
6M
-22.9%
YTD
-45.2%
1Y
-26.6%
Scan Membership
Breakout Watch
Latest: 2024-10-03
5 appearances in last 60 days. First seen: 2018-10-16.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S4
Wk 11 · Vol 0.34x
2026-10-21S4
Wk 11 · Vol 0.51x
2026-10-20S4
Wk 11 · Vol 0.43x
2026-10-19S4
Wk 10 · Vol 0.63x
2026-10-16S4
Wk 10 · Vol 0.61x
2026-10-15S4
Wk 10 · Vol 0.75x
2026-10-14S4
Wk 10 · Vol 1.18x
2026-10-13S4
Wk 10 · Vol 1.21x
2026-10-12S4
Wk 9 · Vol 0.62x
2026-10-09S4
Wk 9 · Vol 0.78x
2026-10-08S4
Wk 9 · Vol 0.91x
2026-10-07S4
Wk 9 · Vol 0.43x
Moving averages & range
50 DMA
$3.16
200 DMA
$4.10
52W High
$6.52
52W Low
$2.93
5D Low
$3.00
Resistance levels (recent highs)
20d High
$3.21
60d High
$4.24
120d High
$4.60
250d High
$6.52
Next resistance
+4.4%
to 20d High
ROE
-10.5%
Profit margin -4.0%
Dividend Yield
0.00%
P/B 7.9

KORU Medical Systems: quick answers

What stage is KORU Medical Systems in?

As of Oct 22, 2026, KORU Medical Systems (KRMD) is in Stage 4, the downtrend phase. It entered Stage 4 on Aug 10, 2026 and is in week 11. What the four stages mean

Is KORU Medical Systems in an uptrend?

No. KORU Medical Systems is in a Stage 4 downtrend. It trades 24.9% below its 200-day average, which is falling.

How far is KORU Medical Systems from its 52-week high?

KORU Medical Systems closed at $3.08 on Oct 22, 2026, 52.8% below its 52-week high of $6.52. Its 52-week low is $2.93.

How has KORU Medical Systems performed over the past year?

As of Oct 22, 2026, KORU Medical Systems is down 26.6% over the past year and down 45.2% so far in 2026.

Which sector and industry is KORU Medical Systems in?

KORU Medical Systems is in the Medical Instruments & Supplies industry, part of the Health Care sector.

About this companyHealth Care· Medical Instruments & Supplies

KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the FREEDOM infusion systems to deliver therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobinuria (PNH). Its products include the FREEDOM60 Syringe Driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company was formerly known as Repro Med Systems, Inc. and changed its name to KORU Medical Systems, Inc. in March 2022. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Mahwah, New Jersey.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.